According to a recent LinkedIn post from Impress, the company is highlighting external recognition for its co‑founder and COO, Diliara Lupenko, who was named among Europe’s 100 most influential women in startups and VC by EU‑Startups. The post emphasizes her role in overseeing operations for a European healthtech business with more than 1,000 employees in 10 countries, operating across varied regulatory environments and languages.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
The company’s LinkedIn post suggests that Lupenko has been central in building Impress’s operations, technology infrastructure, and patient experience since inception. For investors, this kind of leadership recognition may signal operational depth and execution capability, factors that can be important for scaling a multi‑country healthtech platform and managing regulatory complexity.
The emphasis on cross‑border operational management indicates that Impress is positioned as a pan‑European orthodontics and healthtech provider rather than a single‑market player. If sustained, this operational scale and recognition could support future growth, strengthen brand credibility in the healthtech space, and potentially enhance the company’s competitive standing when pursuing capital, partnerships, or expansion initiatives.